Cultivating regenerative medicine innovation in China

Regenerative Medicine

Volumn 5, Issue 1, 2010, Pages 35-44

  McMahon, Dominique S ^a   Thorsteinsdttir, Halla ^a,b   Singer, Peter A ^a   Daar, Abdallah S ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

China; Innovation; Regenerative medicine; Stem cell therapy

Indexed keywords

GENDICINE; LITHIUM SALT;

ADULT STEM CELL; ARTICLE; CEREBRAL PALSY; CHINA; CLINICAL TRIAL; CORD BLOOD STEM CELL TRANSPLANTATION; EMBRYONIC STEM CELL; EVIDENCE BASED MEDICINE; GENE THERAPY; GOVERNMENT REGULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERVIEW; MEDICAL LITERATURE; MEDICAL RESEARCH; MESENCHYMAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PARKINSON DISEASE; PATIENT SAFETY; PRIORITY JOURNAL; PUBLICATION; REGENERATIVE MEDICINE; RESEARCH ETHICS; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION; STROKE; THERAPY EFFECT; TRAUMATIC BRAIN INJURY; ANIMAL; HISTORY; STEM CELL;

ANIMALS; BIOMEDICAL RESEARCH; CHINA; HISTORY, 21ST CENTURY; HUMANS; REGENERATIVE MEDICINE; STEM CELLS;

EID: 77449087566     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/rme.09.78     Document Type: Article

References (24)

1. Zweig D: Competing for talent: China's strategies to reverse the brain drain. Int. Labour Rev. 145, 65-89 (2006).
2. Tong DZ, Wu SQ, Ye YF, Yang SY, Du M, Lu DY: Nuclear transfer in fishes. Chinese Sci. Bull. 7, 60-61 (1963).
3. Tong DZ, Ye YH, Lu DY, Tong SM, Du M: Transplantation of nuclei between two subfamilies of teleosts. Acta Zool. Sin. 19, 201-207 (1973).
4. Zhou Q, Renard J, Le Friec G: Generation of fertile cloned rats by regulating oocyte activation. Science 302, 1179 (2003).
5. Chen Y, He ZX, Liu AL et al.: Embryonic stem cells generated by nuclear transfer of human somatic nuclei into rabbit oocytes. Cell Res. 13, 251-263 (2003).
6. Abbott A, Dennis C, Ledford H, Smith K: The lure of stem-cell lines. Nature 442, 336-337 (2006).
7. Guhr A, Kurtz A, Friedgen K, Loser P: Current state of human embryonic stem cell research: an overview of cell lines and their use in experimental work. Stem Cells 24, 2187-2191 (2006).
8. Liao LM, Zhao RC: An overview of stem cell-based clinical trials in China. Stem Cells Dev. 17, 613-618 (2008).
9. Cheng L, Xiao L, Zeng F, Zhang YA: Stem cells shine in Shanghai. Cell Stem Cell 2, 34-37 (2008).
10. Lander B, Thorsteinsdóttir H, Singer PA, Abdallah AS: Harnessing stem cells for health needs in India. Cell Stem Cell 3, 11-15 (2008).
11. Guest J, Herrera LP, Qian T: Rapid recovery of segmental neurological function in a tetraplegic patient following transplantation of fetal olfactory bulb-derived cells. Spinal Cord 44, 135-142 (2006).
12. Dobkin BH, Curt A, Guest J: Cellular transplants in China: observational study from the largest human experiment in chronic spinal cord injury. Neurorehabil. Neural Repair 20, 5-14 (2006).
13. Radtke C, Sasaki M, Lankford KL, Vogt PM, Kocsis JD: Potential of olfactory ensheathing cells for cell-based therapy in spinal cord injury. J. Rehabil. Res. Dev. 45, 141-152 (2008).
14. Liao LM, Li LS, Zhao RC: Stem cell research in China. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 362, 1107-1112 (2007).
15. Doring O: China's struggle for practical regulations in medical ethics. Nat. Rev. Gen. 4, 233-239 (2003).
16. Chinese National Human Genome Center at Shanghai, Ethics Committee: Ethical guidelines for human embryonic stem cell research (a recommended manuscript). Kennedy Inst. Ethics J. 14, 47-54 (2004).
17. Ministry of Science and Technology; Ministry of Health: Ethical guiding principles for human embryonic stem cell research. People's Republic of China (2003).
18. Hao X: Monkey research in China: developing a natural resource. Cell 129, 1033-1036 (2007).
19. Cheng L, Qiu RZ, Deng H, Zhang YA, Jin Y, Li L: Ethics: China already has clear stem-cell guidelines. Nature 440, 992 (2006).
20. Cyranoski D: Stem-cell therapy faces more scrutiny in China. Nature 459, 146-147 (2009).
21. Anonymous ISSCR Guidelines for the Clinical Translation of Stem Cells: Current Protocols in Stem Cell Biology. Appendix 1, 1B (2009).
22. Salter B, Cooper M, Dickins A: China and the global stem cell bioeconomy: an emerging political strategy? Regen. Med. 1, 671-683.
23. Frew S, Sammut SM, Shore AF et al.: Chinese health biotech and the billion-patient market. Nature Biotechnol. 26, 37-53 (2008).
24. Mandavilli A: Hui Zhen Sheng. Nat. Med. 12, 265-266 (2006).